Building Resilient Supplier Relationships, Leveraging AI-Driven Efficiency & Maximizing Value Through More Strategic Procurement
R&D procurement has never carried more weight. Outsourcing now accounts for roughly a quarter of pharma R&D costs, and supplier consolidation is shrinking your options. Tariffs and the BIOSECURE Act are redrawing global supply chains, and your team is expected to deliver more with the same headcount.
The 11th R&D Procurement & Sourcing in Pharma Summit returns to Boston as the only event built exclusively for biopharma R&D procurement. It unites clinical, preclinical and strategic sourcing leaders from pharma and biotech in one focused, single-track room. The summit is pharma- and biotech-led, never vendor-led, with real case studies, candid peer discussion and interactive sessions where you build, not just listen.
New for 2027, the AI Real-World Implementation Day moves AI from pilot to practice. Benchmark your AI maturity against peers, see live deployments and build your own agentic workflow before you leave.
The summit arrives less than three months after the first BIOSECURE list of biotechnology companies of concern is due. That makes it your moment to stress-test your supply base and sharpen your category strategy. You’ll return with a completed vendor scorecard, practical strategies for tariffs and scarce capacity, and a network of peers facing the same challenges you do.
Attending Companies Include